Skip to main content Accessibility help

Comparative dosimetric analysis of whole abdominal radiotherapy with VMAT versus 3D conformal in patients with Wilms tumour

  • Alejandro Olmos (a1), Alejandro Rodriguez (a1), Estefania Beltran (a1), Onix Garay (a1), Armando Felix (a1), Mario Alberto Ponce (a1), Maurico Salcedo (a1), Teresa Apresa (a1), Lorena Lio (a1), Martha Guzman (a1) and Fatima Chilaca (a1)...

In this study, we undertake a dosimetric comparison of whole abdominal treatment plans of patients diagnosed with stage 3 Wilms tumour, to assess the benefits of treating these patients with volumetric arch therapy (VMAT) versus 3D conformal radiotherapy.

Material and methods

A retrospective study was undertaken on 23 patients receiving either VMAT or 3D conformal radiotherapy during 2013–2017. A dosimetric comparison was undertaken for both techniques, measuring planning target volume (PTV), conformity index (CI), homogeneity index (HI) and organs at risk (OAR).


The dosimetric parameters for the PTV dose in the VMAT and 3D conformal technique showed no statistical difference (1,289·17 cGy versus 1,357·13 cGy, respectively, p=0·404). However, the VMAT technique had a better CI (1·04 VMAT versus 1·26 3D, p=0·004), and there was little difference in the HI (1·13 VMAT versus 1·15 3D, p=0·1606). In the statistical analysis, the decrease in dose to OAR for the VMAT technique is statistically significant for doses to lung and kidney (p=0·011 and p=0·002, respectively). Between the two techniques, there was no statistical significance in dose difference to the other OAR.


This work proposes using the VMAT technique in whole abdominal irradiation to improve conformity, without affecting the quality of the PTV coverage, when compared with the 3D conformal technique. In addition, VMAT reduces the doses to OAR such as the remaining kidney and lungs that are important to preserve to reduce the probability of radiation toxicity in these patients.

Corresponding author
Author for correspondence: Alejandro Olmos, Oncology Hospital, Radiotherapy Department, National Medical Center XXI Century, Mexican Social Security Institute, México City, Mexico, Cuauthemoc 330, Col Doctores, Ciudad de Mexico, Ciudad de Mexico, 06720. (E-mail:
Hide All

Cite this article: Olmos A, Rodriguez A, Beltran E, Garay O, Felix A, Ponce MA, Salcedo M, Apresa T, Lio L, Guzman M, Chilaca F. (2019) Comparative dosimetric analysis of whole abdominal radiotherapy with VMAT versus 3D conformal in patients with Wilms tumour. Journal of Radiotherapy in Practice page 1 of 3. doi: 10.1017/S1460396918000778

Hide All
1. Ehrlich, P F, Ritchey, M L, Hamilton, T E et al. Quality assessment for Wilms’ tumor: a report from the National Wilms’ Tumor Study-5. J Pediatr Surg 2005; 40 (1): 208213.
2. Dalul, J, Nicolás, M, Nicolás, Q, Alberto, D, Diego, G, Rodolfo, R. Tumor de Wilms en el adulto. Revista Argentina de Urología 2011; 76 (3): 137140.
3. Zapata, M, González, O, Pérez, F et al. “Tumor de Wilms” Capítulo 18 En Rivera, R. Protocolos técnicos, Cáncer de Niños. Consejo Nacional para la Prevención y el Tratamiento del Cáncer en la Infancia y la Adolescencia. 1ª Edición, Editores de Textos Mexicanos SA de CV, Ciudad de México, México, 2010.
4. Ferris, J, Berbel, O, Ortega, J A, López, J A, García, J, Balaguer, J. Factores de Riesgo para los tumores renales malignos pediátricos. Revista Española Pediátrica 2003; 59 (6): 527536.
5. Hernández Fernández, R. El tumor de Wilms. Un paradigma de heterogeneidad genética, Revista Habanera de Ciencias Médicas, ciudad de la Habana Cuba 2011; 10 (2): 213223.
6. Davidoff A M. Wilms tumor review. Adv Pediatr 2012; 59 (1): 247267.
7. Beckwith, J B, Palmer, N F. Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer 1978; 41: 19371948.
8. Grundy, P E, Breslow, N E, Li, S et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 2005; 23: 73127321.
9. Green, D M, Beckwith, J B, Weeks, D A, Moksness, J, Breslow, N E, D’Angio, G J. The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with stage I/favorable histology Wilms’ tumor. A report from the National Wilms’ Tumor study. Cancer 1994; 74 (6): 1817e20.
10. Weirich, A, Ludwig, R, Graf, N et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/ GPOH with respect to relapse and morbidity. Ann Oncol 2004; 15 (5): 808e20.
11. D’Angio, G J. The treatment of Wilms’ tumor. Results of the national Wilms’ tumor study. Cancer 1976; 38 (2): 633646.
12. Green, D M. The treatment of stages I–IV favorable histology Wilms’ tumor. J Clin Oncol 2004; 22: 13661372.
13. De Kraker, J, Graf, N, van Tinteren, H, Pein, F, Sandstedt, B, Godzinski, J, Tournade, MF. Reduction of postoperative chemotherapy in children with stage I intermediaterisk and anaplastic Wilms’ tumour (SIOP 93-01 trial): a randomized controlled trial. Lancet 2004; 364 (9441): 12291235.
14. Halperin, E, Constine, L, Tarbell, N et al (eds.) Pediatric Radiation Oncology, 5th edition. Philadelphia, PA: Lippincott Williams & Wilkins, 2011: 257289.
15. Van’t Riet, A, Mak, A C, Moerland, MA et al. A conformation number to quantify the degree of conformity in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 1997; 37: 731736.
16. Feuvret, L, Noël, G, Mazeron, J-J, Bey, P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006; 64 (2): 333342.
17. Newhauser, W D, Durante, M. Assessing the risk of the second malignancies after modern radiotherapy. Nat Rev Cancer 2011; 11: 438448.
18. Chojnacka, M, Zygmuntowicz-Piętka, A, Semaniak, A, Pędziwiatr, K, Dąbrowski, R, Skowrońska-Gardas, A. Volumetric modulated arc therapy versus 3D conformal radiotherapy for selected childhood neoplasms. J Radiother Practice 2014; 14 (01): 3542.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Radiotherapy in Practice
  • ISSN: 1460-3969
  • EISSN: 1467-1131
  • URL: /core/journals/journal-of-radiotherapy-in-practice
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed